Roche and Lonza Announce Opt-in for Singapore Manufacturing Facility
31-Aug-2009 -
Roche and Lonza announced that Genentech Singapore Pte. Ltd., a wholly-owned member of the Roche Group, elected to exercise an option to purchase from Lonza its cell culture biologic manufacturing facility in Singapore. The facility, which is mechanically complete, will be merged with Genentech ...
biotechnology
cell cultures
fermentation
+5